SKI Market

A+| A| A-|

Indian Indices

Sensex

72,696.39 -1,836.57
( -2.46%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

51,583.72 -1,788.81
(-3.35%)

Nikkei 225

9,923.24 4.91
(0.05%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

228.13

50.92

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

prismx global ventures ltd

Dar Credit & Capital standalone net profit rises 40.00% in the December 2025 quarter

Feb 12,2026

Net profit of Dar Credit & Capital rose 40.00% to Rs 2.52 crore in the quarter ended December 2025 as against Rs 1.80 crore during the previous quarter ended December 2024. Sales rose 25.10% to Rs 12.56 crore in the quarter ended December 2025 as against Rs 10.04 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	12.56	10.04	25
OPM %	70.30	69.82	-
PBDT	3.55	2.55	39
PBT	3.35	2.38	41
NP	2.52	1.80	40

72,696.39 -1,836.57 ( -2.46%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

51,583.72 -1,788.81 (-3.35%)

9,923.24 4.91 (0.05%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)